Impact1 Voices

Pathways for Small Patient Populations with Andre Bessette


Listen Later

Andre Bessette is the CEO of Eclipse Regenesis, a company developing a mechanical solution to short bowel syndrome. In this episode, Andre highlights the regulatory pathways available to solutions addressing needs in small patient populations. He also discusses clinical study site selection, payor engagement, and the current challenges of short bowel syndrome and necrotizing enterocolitis care.

...more
View all episodesView all episodes
Download on the App Store

Impact1 VoicesBy Impact1 at Stanford Biodesign